Judge Denies Centocor's Motions for Summary Judgment, Exclude Expert
April 29, 2004
DOCUMENTS
- Memorandum and Order
ST. LOUIS, Mo. - Remicade manufacturer Centocor's motion for summary judgment was denied April 15 by a federal judge, who ruled that there were genuine issues of material fact that precluded granting the motion. Rolwes v. Centocor, Inc., et al. No. 03-CV-151 (E.D. Mo.).
U.S. District Judge Charles A. Shaw also denied the company's motion in limine to exclude the opinions of plaintiff's expert Dr. Donald Marks, finding that his opinions satisfied the standards established under Daubert.
Summary Judgment
Centocor and its parent company Johnson & Johnson moved for summary judgment Feb. 17 on the ground that Janet Rolwes …
UPCOMING CONFERENCES

HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
April 08, 2025 - Long Beach, CA
The Westin Long Beach